Effort of Breathing Guided Ventilator Protocol (EOBvent)
Primary Purpose
Ventilators, Mechanical, Work of Breathing
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Ventilator protocol
Esophageal Catheter
Sponsored by
About this trial
This is an interventional treatment trial for Ventilators, Mechanical focused on measuring pediatrics, ventilator weaning
Eligibility Criteria
Inclusion Criteria:
- Intubated and mechanically ventilated patients in the Children's Hospital Los Angeles Pediatric ICU
- Anticipated length of intubation > 48 hours.
- The primary attending physician approves use of the protocol on the patient.
Exclusion Criteria:
- Corrected gestational age less than 37 weeks
- Contraindications to nasoesophageal catheter placement (nasopharyngeal or esophageal abnormalities) or Respiratory Inductance Plethysmography bands (abdominal wall defects such as omphalocele).
- Significant lower airway obstruction (asthma or bronchiolitis), confirmed by ventilator spirometry
Sites / Locations
- Children's Hospital Los Angeles
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intervention Arm
Arm Description
Ventilator management using the proposed protocol in both acute and weaning phases. Patients will be managed according the the Ventilator protocol using the esophageal catheter for the weaning phase
Outcomes
Primary Outcome Measures
Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider
The investigators will track the percentage of recommendations which are accepted by providers, as well as the reasons why recommendations were not accepted
Secondary Outcome Measures
Full Information
NCT ID
NCT02989246
First Posted
December 6, 2016
Last Updated
October 21, 2021
Sponsor
Children's Hospital Los Angeles
1. Study Identification
Unique Protocol Identification Number
NCT02989246
Brief Title
Effort of Breathing Guided Ventilator Protocol
Acronym
EOBvent
Official Title
Effort of Breathing Guided Ventilator Management for Children Using Pressure Rate Product: a Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
February 1, 2015 (undefined)
Primary Completion Date
October 18, 2017 (Actual)
Study Completion Date
December 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital Los Angeles
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot study tests the feasibility of using a computerized ventilator management protocol seeking to encourage lung protective ventilation during the acute phase of ventilation, and esophageal manometry based titration of ventilator settings during the weaning phase of ventilation, for children with acute respiratory failure. The investigators hypothesize that such an approach will reduce time on mechanical ventilation, largely by preserving diaphragm muscle function.
Detailed Description
Objectives: This pilot study will help refine a computer based ventilator management protocol which will be used in both acute and weaning phases of ventilation for children with acute respiratory failure. The acute phase protocol is an adaptation of the Acute Respiratory Distress Syndrome Network protocol for pediatrics, and the weaning phase involves an esophageal manometry guided weaning protocol based on effort of breathing. The investigators seek to test the safety and feasibility of the protocol recommendations and the software system , and help determine the potential effect size of the intervention to determine feasibility of a randomized controlled trial. They also seek to determine the feasibility and reproducibility of serial diaphragm ultrasound measurements on mechanically ventilated children.
Study Population: All children intubated and mechanically ventilated in the Children's Hospital Los Angeles Pediatric ICU with an anticipated length of intubation > 48 hours will be eligible, with some exclusion criteria based on ability to perform the measurements.
Study methodology: After consent, an esophageal catheter will be placed. A software management tool for ventilator management will be placed at the bedside for each enrolled patient, and recommendations regarding changing ventilator support will be provided to the clinicians every several hours during both acute and weaning phases. When ventilator support is below a threshold, recommendations will be made to perform spontaneous breathing trials. The clinicians will ultimately decide whether to accept or reject the recommendations, and will evaluate the patient before each potential change to the ventilator. The acceptance or rejection of recommendations will be tracked, and used to refine the intervention. Daily diaphragm ultrasound measurements will also be obtained to monitor diaphragm thickness and contractile activity.
Follow up: Clinical outcomes will be followed while in the ICU including re-intubation, medications administered, and ICU length of stay. No follow up after ICU discharge is planned.
Analysis plans: Data will be used to refine the intervention, test the acceptability of protocol recommendations to bedside providers, and determine sample size estimates for a follow up randomized controlled trial. These analyses will be descriptive. A pilot of 40 patients is anticipated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventilators, Mechanical, Work of Breathing
Keywords
pediatrics, ventilator weaning
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention Arm
Arm Type
Experimental
Arm Description
Ventilator management using the proposed protocol in both acute and weaning phases. Patients will be managed according the the Ventilator protocol using the esophageal catheter for the weaning phase
Intervention Type
Other
Intervention Name(s)
Ventilator protocol
Intervention Description
Open loop ventilator management by a computer based protocol
Intervention Type
Device
Intervention Name(s)
Esophageal Catheter
Intervention Description
Esophageal manometry measurements of patient effort of breathing will be used to guide the protocol recommendations
Primary Outcome Measure Information:
Title
Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider
Description
The investigators will track the percentage of recommendations which are accepted by providers, as well as the reasons why recommendations were not accepted
Time Frame
With each protocol recommendation, approximately every 4 hours during the course of mechanical ventilation (up to 28 days)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
37 Weeks
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Intubated and mechanically ventilated patients in the Children's Hospital Los Angeles Pediatric ICU
Anticipated length of intubation > 48 hours.
The primary attending physician approves use of the protocol on the patient.
Exclusion Criteria:
Corrected gestational age less than 37 weeks
Contraindications to nasoesophageal catheter placement (nasopharyngeal or esophageal abnormalities) or Respiratory Inductance Plethysmography bands (abdominal wall defects such as omphalocele).
Significant lower airway obstruction (asthma or bronchiolitis), confirmed by ventilator spirometry
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robinder Khemani, MD
Organizational Affiliation
Children's Hospital Los Angeles
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90027
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effort of Breathing Guided Ventilator Protocol
We'll reach out to this number within 24 hrs